MARLBOROUGH, Mass., March 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTC Bulletin Board: ACTC), a leader in the field of regenerative medicine, announced today that Gary Rabin, the company's interim chairman and chief executive officer, will be presenting at the BIO-Europe Spring 2011 Conference, March 14-16, at the Milano Convention Centre in Milan, Italy. Mr. Rabin's presentation is scheduled for Wednesday, March 16, at 10:15 a.m. CET, level 1, room Yellow 3.
Webcasting is not available but following the conference a copy of Mr. Rabin's slide deck will be available on the company's Web site at http://www.advancedcell.com.
About Advanced Cell Technology, Inc.Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.
Forward-Looking StatementsStatements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history,
|SOURCE Advanced Cell Technology, Inc.|
Copyright©2010 PR Newswire.
All rights reserved